We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Exonate has successfully fundraised £1.5 million to accelerate development of its lead product - an eye drop treatment for retinal neovascular diseases.